🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the safety and immunogenicity of new for...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-12-09
Trial ID
NCT01248884
Treatments Being Tested
In this study, infants who were previously vaccinated with hepatitis B vacc...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-12
Trial ID
NCT00316147
Treatments Being Tested
The primary immunogenicity objective is to assess and compare the immunogen...
Status
Completed
Location
Site 22
Start Date
2008-03
Trial ID
NCT00667602
Treatments Being Tested
Assess immuno, reacto of the 10-valent pneumococcal vaccine after 2 doses (...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-01-01
Trial ID
NCT00307034
Treatments Being Tested
This study will evaluate the immunogenicity of the co-administration of dif...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-09-30
Trial ID
NCT00352963
Treatments Being Tested
The purpose of this Phase II study is to evaluate the feasibility of GSK Bi...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-24
Trial ID
NCT00871338
Treatments Being Tested
This study evaluates the immunogenicity and safety of Infanrix hexa™ (DTPa-...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-16
Trial ID
NCT01353703
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of B...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-27
Trial ID
NCT03621670
This is a booster study in 2 groups of healthy children less than 3 years o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-08-22
Trial ID
NCT00513409
Treatments Being Tested
This study assessed the immunogenicity and safety of two vaccination regime...
Status
Completed
Location
Multiple Locations
Start Date
2001-09
Trial ID
NCT00366366
Treatments Being Tested